Mucosolvan Market

Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is the active ingredient of Mucosolvan, Lasolvan or Mucoangin. The substance is a mucoactive drug with several properties including secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract which play an important role in the body?s natural defence mechanisms. It stimulates synthesis and release of surfactant by type II pneumocytes. Surfactants acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents.
Mucosolvan Market contains market size and forecasts of Mucosolvan (Ambroxol) in Global, including the following market information:
Global Mucosolvan (Ambroxol) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Mucosolvan (Ambroxol) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mucosolvan (Ambroxol) include Zywie LLC, Sanofi, Hanmi, Adare Pharma, Boehringer Ingelheim, Teijin, Astellas Pharma, Chiesi and Sidus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mucosolvan (Ambroxol) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mucosolvan (Ambroxol) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mucosolvan (Ambroxol) Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsules
Injections
Solutions
Syrups
Granules
Global Mucosolvan (Ambroxol) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Mucosolvan (Ambroxol) Market Segment Percentages, by Application, 2021 (%)
Acute And Chronic Bronchitis
Bronchial Asthma
Bronchiectasis
Emphysema
Tuberculosis (TB)
Pneumoconiosis
Postoperative Medication
Other
Global Mucosolvan (Ambroxol) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Mucosolvan (Ambroxol) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mucosolvan (Ambroxol) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Mucosolvan (Ambroxol) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zywie LLC
Sanofi
Hanmi
Adare Pharma
Boehringer Ingelheim
Teijin
Astellas Pharma
Chiesi
Sidus
Takeda
Euderma
Changzhou Siyao Pharmaceuticals
Shandong Fangming Pharmaceutical Group
TIPR Pharmaceutical
Hainan Weikang Pharmaceutical
Sandoz (Novartis)
Sinopharm
Jiangsu Hengrui Pharmaceutical
Yantai Dongcheng Dayang Pharmaceutical
Zhuhai Tongyuan Pharmaceutical
Beijing Taiyang Pharmaceutical
Nanjing Yihua Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Shandong Yuxin Pharmaceutical
CSPC
Shanxi Qianyuan Pharmaceutical Group
Yangtze Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Shenyang Xinma Pharmaceutical